Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
06/1995
06/27/1995CA1336081C Process for the preparation of hydroxy acids
06/27/1995CA1336080C Peptide derivatives, a process for the preparation thereof, and the use thereof
06/22/1995WO1995016711A1 Antibodies against pneumolysine and their applications
06/22/1995WO1995016457A1 Aspartame for use as a therapeutically active substance
06/22/1995DE4342560A1 Use of 1,4,5,6-tetra:hydro-4-pyrimidine carboxylic acid derivs. in cosmetics
06/21/1995EP0658585A2 Aminophenylalanine derivatives, process for their production, their use and agents containing them as anti-coagulants
06/21/1995EP0658169A1 Diamino acid derivatives as antihypertensives
06/21/1995EP0658115A1 Peptide medicaments for treating disease
06/21/1995CN1028962C Stabilization medicines, process for producing them and slabilization pharmaceutical composition
06/20/1995US5426185 Antiarrhythmia agents having reduced side effects
06/20/1995US5426103 Certain macrocyclic lactam derivatives
06/20/1995US5425936 Useful for therapeutic, prophylactic and diagnostic purposes
06/20/1995US5425787 Method for crystallization of α-L-aspartyl-L-phenylalanine methyl ester
06/15/1995WO1995016209A1 Process for the production of combinatorial compound libraries
06/15/1995WO1995016029A1 Mutants of a thermostable neutral protease from bacillus
06/15/1995WO1995015973A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995WO1995014028A3 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
06/15/1995CA2177840A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995CA2177381A1 Novel protease ii
06/15/1995CA2175078A1 Process for the production of combinatorial compound libraries
06/14/1995EP0657467A1 Antitumor antibiotics
06/14/1995EP0657453A1 Angiotensin converting enzyme (ace) inhibitors containing a fused multiple ring lactam
06/14/1995EP0657416A1 Process for recovering L-phenylalanine
06/14/1995EP0657029A1 Calcium receptor active molecules
06/14/1995EP0656907A1 Conformationally restricted mimetics of reverse turns and peptides containing the same
06/14/1995EP0656903A1 Methods and compositions for the identification, characterization, and inhibition of farnesyltransferase
06/14/1995EP0656902A1 Peptide lung surfactants and therapeutic combinations
06/14/1995EP0656887A1 Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
06/14/1995EP0471833B1 Method for increasing the alpha to beta ratio in an aspartame coupling reaction
06/13/1995US5424477 Reducing an aqueous suspension of N-benzyloxycarbonyl-phenyl-alanine methyl ester in presence of hydrogenation catalysts and particles of N-benzyloxy-aspartyl-phenylalanine methyl ester
06/13/1995US5424454 2,2,-dichloropropionyl-L-proline
06/13/1995US5424426 Dithiolanylglycine-containing HIV protease inhibitors of the hydroxyethylene isostere type
06/13/1995US5424425 Analgesics, antidepressants, hypotensive agent and treats irritable bowel syndrome and congestive heart failure
06/13/1995US5424396 Containing three to six amino acids
06/13/1995US5424309 Hypotensive agents
06/13/1995US5424293 Phenylimidazolidine derivatives and their use
06/13/1995US5424292 5-aminosalicylic acid derivatives for the therapy of chronic inflammatory bowel diseases
06/13/1995US5424291 Isosteric peptides
06/07/1995EP0656356A1 Dioxacycloalkane compound with renin-inhibiting activity
06/07/1995EP0656009A1 Glycyl-hystidyle-lysine (ghl) derivatives
06/07/1995EP0656008A1 Thrombin receptor antagonists
06/06/1995US5422426 Solid phase synthesis of oligopeptides for testing as ligands for enzymes and cellular receptors; controlling the concentration and ratios
06/06/1995US5422342 A hydrolase inhibitor comprising a protected oligopeptides for treating fibrose of lungs, liver and skins, atherosclerosis
06/06/1995US5422110 Enhanced immunogenicity using leukotoxin chimeras
06/01/1995WO1995014706A1 Pna-dna-pna chimeric macromolecules
06/01/1995WO1995014666A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
06/01/1995WO1995014655A1 Diastereoselective synthesis of hydroxyethylene dipeptide isosteres
06/01/1995WO1995014471A1 Antiarrhythmic benzodiazepines
06/01/1995CA2176140A1 Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
06/01/1995CA2176015A1 Antiarrhythmic benzodiazepines
05/1995
05/31/1995EP0655462A1 Linear adhesion inhibitors
05/31/1995EP0655461A1 Cyclic amino acid derivatives having ACE and NEP inhibiting activity
05/31/1995EP0655460A1 Pharmacotherapeutical use of glutathione derivatives
05/31/1995EP0655069A1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
05/31/1995EP0655068A1 Process for synthesizing a beta-aminoalkylboronic acid and ester thereof
05/31/1995EP0655067A1 Beta-aminoalkyl and beta-n-peptidylaminoalkyl boronic acids
05/31/1995CN1103068A Amino-acid low peptide preparing method
05/30/1995US5420347 Processes and intermediates for N-(S-3-alkyl-heptanoyl)-D-gamma-glutamyl-glycyl-D-alanine
05/30/1995US5420338 Method for the production of α-L-aspartyl-L-phenylalanine methyl ester hydrochloride
05/30/1995US5420328 Esterification with alcohol and hydrolysis
05/30/1995US5420297 Peptides having substance P antagonistic activity
05/30/1995US5420246 Having a predetermined amount of each peptide
05/30/1995US5420245 Tetrapeptide-based inhibitors of farnesyl transferase
05/30/1995US5420113 [Leu13]motilin, DNAs coding for same and methods for producing same
05/30/1995US5420109 Cytokine restraining agents
05/26/1995WO1995014033A1 Novel dipeptide derivatives
05/26/1995WO1995014028A2 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995WO1995014008A1 Substituted 5-ring heterocycles, their preparation and their use
05/26/1995WO1995013826A1 Preventive and remedy for allergic disease
05/26/1995WO1995013817A1 Endothelin converting enzyme inhibitors
05/26/1995WO1994027584A3 Arylating medicaments
05/26/1995CA2176808A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
05/26/1995CA2169643A1 Substituted 5-ring heterocycles, their preparation and their use
05/24/1995EP0654481A1 Process for producing alpha-L-aspartyl-L-phenylalanine methyl ester
05/24/1995EP0654480A1 Process for producing alpha-L-aspartyl-L-pheylalanine methyl ester
05/24/1995EP0654041A1 Peptidyl 4-amino-2,2-difluoro-3-oxo-1,6-hexanedioic acid derivatives as antiinflammatory agents
05/24/1995CA2135587A1 Antitumor antibiotics
05/23/1995US5418218 Controlling food intake
05/23/1995US5418146 Process for preparing dipeptides
05/23/1995CA1335686C Vinblastin and pharmaceutical composition comprising them
05/19/1995CA2134149A1 Compounds containing a fused multiple ring lactam
05/18/1995WO1995013289A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/18/1995WO1995013274A1 Antithrombotic amidinophenylalanine and amidinopyridylalanine derivatives
05/18/1995WO1995013086A1 Cytokine restraining agents
05/18/1995WO1995013069A1 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
05/18/1995DE4338944A1 New imidazolidone, oxazolidone, thiazolidone or pyrrolidone derivs.
05/18/1995CA2175564A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease
05/18/1995CA2175218A1 Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
05/18/1995CA2173470A1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
05/17/1995EP0652952A1 Peptides inhibiting ras protein activity, preparation and use thereof
05/17/1995EP0652893A1 Kininogenase inhibitors
05/17/1995EP0652887A1 New derivatives of neuraminic acid
05/17/1995EP0652863A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression
05/17/1995CA2135711A1 Cyclic amino acid derivatives
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416093 Dipeptide derivatives
05/16/1995US5416070 Composition for macrophage activation
05/16/1995US5416013 DNA sequences of polypeptides from genetic engineering
05/16/1995CA1335568C Cosmetic and skin treatment compositions
05/11/1995WO1995012655A1 Liquid detergents with ortho-substituted phenylboronic acids for inhibition of proteolytic enzyme
1 ... 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 ... 307